{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:57:15Z","timestamp":1770220635420,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JSPS KAKENHI 16K19603"],"award-info":[{"award-number":["JSPS KAKENHI 16K19603"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JSPS KAKENHI 15K09527"],"award-info":[{"award-number":["JSPS KAKENHI 15K09527"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H24-Jitsuyoka-Kokusai-004"],"award-info":[{"award-number":["H24-Jitsuyoka-Kokusai-004"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["the Practical Research Project for Rare\/Intractable Diseases"],"award-info":[{"award-number":["the Practical Research Project for Rare\/Intractable Diseases"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13075-019-1823-0","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T14:50:56Z","timestamp":1548255056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I\/II clinical trial conducted in Japan"],"prefix":"10.1186","volume":"21","author":[{"given":"Masahiro","family":"Ayano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Mitoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuteru","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Arinobu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Niiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Nagafuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mine","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"1823_CR1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989\u20132003.","journal-title":"N Engl J Med"},{"key":"1823_CR2","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685\u201399.","journal-title":"Lancet"},{"key":"1823_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/ITT.S82037","volume":"5","author":"P Fuschiotti","year":"2016","unstructured":"Fuschiotti P. Current perspectives on the immunopathogenesis of systemic sclerosis. Immunotargets Ther. 2016;5:21\u201335.","journal-title":"Immunotargets Ther"},{"key":"1823_CR4","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76:1327\u201339.","journal-title":"Ann Rheum Dis"},{"key":"1823_CR5","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1093\/rheumatology\/kew224","volume":"55","author":"CP Denton","year":"2016","unstructured":"Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford). 2016;55:1906\u201310.","journal-title":"Rheumatology (Oxford)"},{"key":"1823_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","volume":"43","author":"VD Steen","year":"2000","unstructured":"Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437\u201344.","journal-title":"Arthritis Rheum"},{"key":"1823_CR7","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/ard.2010.144360","volume":"70","author":"J Fransen","year":"2011","unstructured":"Fransen J, Popa-Diaconu D, Hesselstrand R, Carreira P, Valentini G, Beretta L, et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis. 2011;70:1788\u201392.","journal-title":"Ann Rheum Dis"},{"key":"1823_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.retram.2016.03.003","volume":"64","author":"PJ Kelsey","year":"2016","unstructured":"Kelsey PJ, Oliveira M-C, Badoglio M, Sharrack B, Farge D, Snowden JA. Haematopoietic stem cell transplantation in autoimmune diseases: from basic science to clinical practice. Curr Res Transl Med. 2016;64:71\u201382.","journal-title":"Curr Res Transl Med"},{"key":"1823_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/ard.60.6.577","volume":"60","author":"M Binks","year":"2001","unstructured":"Binks M, Passweg FD, McSweeney P, Sullivan K, Besenthal C, et al. Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis. 2001;60:577\u201384.","journal-title":"Ann Rheum Dis"},{"key":"1823_CR10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/ard.2003.011205","volume":"63","author":"D Farge","year":"2004","unstructured":"Farge D, Passweg J, van Laar JM, Marjanovic Z, Besenthal C, Finke J, et al. Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT\/EULAR registry. Ann Rheum Dis. 2004;63:974\u201381.","journal-title":"Ann Rheum Dis"},{"key":"1823_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/sj.bmt.1705782","volume":"40","author":"Y Oyama","year":"2007","unstructured":"Oyama Y, Barr WG, Statkute L, Corbridge T, E a G, Jovanovic B, et al. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplant. 2007;40:549\u201355.","journal-title":"Bone Marrow Transplant"},{"key":"1823_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood-2007-02-072389","volume":"110","author":"RA Nash","year":"2007","unstructured":"Nash RA, Mcsweeney PA, Crofford LJ, Abidi M, Chen C, Godwin JD, et al. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis\u00a0: long-term follow-up of the US multicenter pilot study. Blood. 2007;110:1388\u201396.","journal-title":"Blood"},{"key":"1823_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/ard.2007.071464","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, Marjanovic Z, van den Hoogen FHJ, Zohar S, Schattenberg a VMB, Fibbe WE, et al. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis. Ann Rheum Dis. 2008;67:98\u2013104.","journal-title":"Ann Rheum Dis"},{"key":"1823_CR14","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/bmt.2012.67","volume":"47","author":"J Moore","year":"2012","unstructured":"Moore J, Englert H, Furlong T, Poon T, Milliken S, Ma D. Auto-HSCT induces sustained responses in severe systemic sclerosis patients failing pulse cyclophosphamide. Bone Marrow Transplant. 2012;47:1486\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"1823_CR15","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(12)62114-X","volume":"381","author":"RK Burt","year":"2013","unstructured":"Burt RK, Oliveira MC, Shah SJ, Moraes DA, Simoes B, Gheorghiade M, et al. Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis. Lancet. 2013;381:1116\u201324.","journal-title":"Lancet"},{"key":"1823_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","volume":"378","author":"RK Burt","year":"2011","unstructured":"Burt RK, Shah SJ, Dill K, Grant T, Gheorghiade M, Schroeder J, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet. 2011;378:498\u2013506.","journal-title":"Lancet"},{"key":"1823_CR17","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1001\/jama.2014.6368","volume":"311","author":"JM van Laar","year":"2014","unstructured":"van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis. JAMA. 2014;311:2490\u20138.","journal-title":"JAMA"},{"key":"1823_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, et al. Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med. 2018;378:35\u201347.","journal-title":"N Engl J Med"},{"key":"1823_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrrheum.2018.34","volume":"14","author":"RK Burt","year":"2018","unstructured":"Burt RK, Farge D. Systemic sclerosis: autologous HSCT is efficacious, but can we make it safer? Nat Rev Rheumatol. 2018;14:189\u201391.","journal-title":"Nat Rev Rheumatol"},{"key":"1823_CR20","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1002\/art.22256","volume":"54","author":"RK Burt","year":"2006","unstructured":"Burt RK, Marmont A, Oyama Y, Slavin S, Arnold R, Hiepe F, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 2006;54:3750\u201360.","journal-title":"Arthritis Rheum"},{"key":"1823_CR21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/bmt.2011.185","volume":"47","author":"JA Snowden","year":"2012","unstructured":"Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation. Bone Marrow Transplant. 2012;47:770\u201390.","journal-title":"Bone Marrow Transplant"},{"key":"1823_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2005.037879","volume":"65","author":"H Tsukamoto","year":"2006","unstructured":"Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, et al. A phase I-II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis. 2006;65:508\u201314.","journal-title":"Ann Rheum Dis"},{"key":"1823_CR23","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/rheumatology\/keq414","volume":"50","author":"H Tsukamoto","year":"2011","unstructured":"Tsukamoto H, Nagafuji K, Horiuchi T, Mitoma H, Niiro H, Arinobu Y, et al. Analysis of immune reconstitution after autologous CD34 + stem\/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4 + t cells. Rheumatology. 2011;50:944\u201352.","journal-title":"Rheumatology"},{"key":"1823_CR24","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"AT Masi","year":"1980","unstructured":"Masi AT. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581\u201390.","journal-title":"Arthritis Rheum"},{"key":"1823_CR25","first-page":"S42","volume":"21","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21:S42\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1823_CR26","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1002\/art.10495","volume":"46","author":"J Moore","year":"2002","unstructured":"Moore J, Brooks P, Milliken S, Biggs J, Ma D, Handel M, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 2002;46:2301\u20139.","journal-title":"Arthritis Rheum"},{"key":"1823_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/bmt.2015.299","volume":"51","author":"MC Oliveira","year":"2016","unstructured":"Oliveira MC, Labopin M, Henes J, Moore J, Del Papa N, Cras A, et al. Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplant. 2016;51:501\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"1823_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.retram.2016.03.004","volume":"64","author":"LCM Arruda","year":"2016","unstructured":"Arruda LCM, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases. Curr Res Transl Med. 2016;64:107\u201313.","journal-title":"Curr Res Transl Med."},{"key":"1823_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.imlet.2017.11.005","volume":"195","author":"FCC van Rhijn-Brouwer","year":"2018","unstructured":"van Rhijn-Brouwer FCC, Spierings J, van Laar JM. Autologous hematopoietic stem cell transplantation in systemic sclerosis: a reset to tolerance? Immunol Lett. 2018;195:88\u201396.","journal-title":"Immunol Lett"},{"key":"1823_CR30","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1182\/blood-2002-06-1929","volume":"101","author":"M Malphettes","year":"2003","unstructured":"Malphettes M, Carcelain G, Saint-Mezard P, Leblond V, Altes HK, Marolleau JP, et al. Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age. Blood. 2003;101:1891\u20137.","journal-title":"Blood"},{"key":"1823_CR31","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/S0140-6736(00)02293-5","volume":"355","author":"DC Douek","year":"2000","unstructured":"Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 2000;355:1875\u201381.","journal-title":"Lancet"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-1823-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-1823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:00:18Z","timestamp":1589551218000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-1823-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1823"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-1823-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"10 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Ethics Committee of Kyushu University Hospital. Written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"30"}}